LOSS PER SHARE (Details) - shares |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Conversion of Series A preferred stock | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares) | 0 | 44,866,071 | 0 | 44,866,071 |
| Series C-3 Warrants | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares) | 0 | 334,516 | 0 | 334,516 |
| Exercise of outstanding options | ||||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
| Anti-dilutive options and warrants excluded from diluted average shares outstanding (in shares) | 0 | 16,083,590 | 0 | 16,083,590 |